Lightcast Launches Envisia™ Platform to Revolutionize Antibody Discovery
May 12, 2025
Limited Release Targets Biotech Innovators with Real-Time Droplet-Based Assays to Accelerate Therapeutic Discovery
Limited Release Targets Biotech Innovators with Real-Time Droplet-Based Assays to Accelerate Therapeutic Discovery
Milestone Approvals Enable European and UK Market Access for AI-Based Cardiac Arrest Prediction Tool
Revolutionary system combines ultrasonics and ultraviolet energy to destroy airborne pathogens and pollutants beyond traditional purification limits.
GE HealthCare (Nasdaq: GEHC)+
today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI system.
Tim Friede has survived hundreds of snakebites—on purpose. For nearly two decades, he let some of the world’s most dangerous snakes sink their fangs into his arms, all for science.
Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a certified lab to be tested on the same test as the doctor’s office, with the same accuracy.
Final approval clears the way for Zydus to market Glatiramer Acetate, expanding access to a key treatment for multiple sclerosis patients in the U.S.
University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.
In recent years, the world has seen a surge in new and deadly infectious diseases, posing a major threat to global health. Outbreaks of COVID-19, H1N1 (swine flu), Ebola, Zika, and monkeypox are a stark reminder of our vulnerability.
Photoactivable drugs are activated when irradiated by a beam of light—via an optical fiber—thus generating a controlled and local therapeutic effect on target tissues. Now, a scientific team has pioneered a new breakthrough in the field of photopharmacology with the design of the first wireless device capable of remotely activating a photoactivable drug and causing it to have therapeutic effects on specific organs.